Aerovate scraps late-stage study for hypertension drug after mid-stage trial fails

(Reuters) – Aerovate Therapeutics said on Monday it is shutting down the late-stage portion of a study testing its experimental hypertension drug after failing to meet the main goal in a mid-stage trial.

(Reporting by Pratik Jain in Bengaluru; Editing by Krishna Chandra Eluri)